Device Medical Device

(6554) Peripheral Vascular Undivided

Payments companies reported to CMS as associated with (6554) Peripheral Vascular Undivided. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$200Kassociated payments (2023-2025)
406clinicians with associated payments
2companies reporting

By year

2023 $34K
2024 $166K

Payments reported as associated with (6554) Peripheral Vascular Undivided, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Vascular Surgery $84K
Vascular & Interventional Radiology $50K
Interventional Cardiology $39K
Cardiovascular Disease $14K
Internal Medicine $2,717
Clinical Cardiac Electrophysiology $1,447

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with (6554) Peripheral Vascular Undivided

These are the largest totals companies reported as associated with (6554) Peripheral Vascular Undivided. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Paul Gagne Darien, CT Vascular Surgery $15,811.50
Kush Desai Chicago, IL Vascular & Interventional Radiology $15,468.23
Erin Murphy Charlotte, NC Vascular Surgery $13,984.90
Micah Watts Galloway, NJ Vascular & Interventional Radiology $12,044.00
Mahmood Razavi Orange, CA Vascular & Interventional Radiology $7,402.25
Sreekumar Madassery Chicago, IL Vascular & Interventional Radiology $6,577.31
Todd Berland New York, NY Vascular Surgery $5,800.16
Hady Lichaa Murfreesboro, TN Cardiovascular Disease $5,635.09
Joseph Ricotta Delray Beach, FL Vascular Surgery $4,898.23
Steven Elias Englewood, NJ Vascular Surgery $4,878.59

Prescribed (6554) Peripheral Vascular Undivided?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.